Cubist Systematic Strategies, LLC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2022$30,000
+20.0%
40,718
+49.5%
0.00%
Q2 2022$25,000
-67.5%
27,240
+103.4%
0.00%
-100.0%
Q2 2021$77,000
-46.5%
13,391
-51.9%
0.00%
-50.0%
Q1 2021$144,00027,8330.00%
Other shareholders
ONCOCYTE CORP shareholders Q3 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 23,353,697$17,048,0001.30%
AWM Investment Company, Inc. 7,746,557$5,655,0000.86%
PURA VIDA INVESTMENTS, LLC 18,056,274$13,181,0000.76%
Defender Capital, LLC. 2,551,980$1,883,0000.74%
Penbrook Management LLC 563,350$411,0000.35%
ACT CAPITAL MANAGEMENT, LLC 330,000$241,0000.33%
CALIBER WEALTH MANAGEMENT, LLC 75,120$55,0000.04%
Fort Sheridan Advisors LLC 135,000$99,0000.03%
Orbimed Advisors 1,882,768$1,374,0000.03%
WEALTH EFFECTS LLC 51,000$37,0000.02%
View complete list of ONCOCYTE CORP shareholders